Multiplexed Matrix-Assisted Laser Desorption/Ionization (MALDI) Mass Spectrometry Imaging (MSI) of Breast Cancer, Prostate Cancer, and Colorectal Cancer for Proteomic and Metabolomic Biomarker Discovery, Validation, and Verification for the Development of

乳腺癌、前列腺癌和结直肠癌的多重基质辅助激光解吸/电离 (MALDI) 质谱成像 (MSI)，用于蛋白质组学和代谢组学生物标志物的发现、验证和验证，以开发

• 批准号: 365421
• 负责人: Luehr Teesha C
• 金额: $ 7.65万
• 依托单位: University of Victoria Genome British Columbia Proteomics Centre (BC)
• 依托单位国家: 加拿大
• 项目类别: Studentship Programs
• 财政年份: 2016
• 资助国家: 加拿大
• 起止时间: 2016-10-01 至 2019-10-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=365421&lang=en
• 关键词: Biomaker; Biomaker Discovery; Biomaker Verification; Breast; Cancer; Colorectal; Diagnosis; Mass Spectrometry; Prognosis; Prostate

Breast cancer (BC), prostate cancer (PC), and colorectal cancer (CRC) are three leading causes of cancer in both incidence rates and mortality worldwide. This trend holds true for Canada; in 2015 25.9% and 11.9% of newly diagnosed cases in women were BC a

乳腺癌（BC）、前列腺癌（PC）和结直肠癌（CRC）是世界范围内发病率和死亡率最高的三大癌症病因。这一趋势适用于加拿大；2015年女性新诊断病例中分别有25.9%和11.9%为BC a